1 min left

0% read

GenBio AI

Software

Foundation

Palo Alto, California, USA

Founded 2024

GenBio.AI, Inc.

GenBio.AI, Inc. (GenBio AI) is an innovative global startup dedicated to developing the world's first AI-driven Digital Organism, an integrated system of multiscale foundation models for predicting, simulating, and programming biology at all levels.

Our goal is to achieve comprehensive, actionable empirical understandings of the mechanisms underlying all organismal physiologies and diseases. This will pave the way for a new paradigm in drug design, bio-engineering, personalized medicine, and fundamental biomedical research, all powered by Generative Biology.

Our founding team consists of world-renowned scientists and researchers in AI and Biology from prestigious institutions such as CMU, MBZUAI, and WIS, alongside prominent financial investors.

GenBio AI, a true global effort from day one, is establishing offices in Palo Alto, Paris, and Abu Dhabi.

Frequently Asked Questions About GenBio AI

GenBio AI is a software company. GenBio.AI, Inc.

Our goal is to achieve comprehensive, actionable.

GenBio AI has been operating since 2024. You can verify their legitimacy through their official website and social media presence.

GenBio AI operates in the software sector of the cryptocurrency industry. Compare GenBio AI with other software companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using GenBio AI, research their track record (operating since 2024), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. GenBio AI is based in Palo Alto, California, USA, has been operating since 2024. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

GenBio AI is based in Palo Alto, California, USA, North America, with offices in Palo Alto, California, USA, Abu Dhabi, Abu Dhabi, ARE, Paris, Île-de-France, FRA.

GenBio AI was founded in 2024. The company currently has 29 employees.

GenBio AI Details

GenBio AI Offices (9)

GenBio AI Tags

More About GenBio AI

Work Model Details

Employees work from physical offices.

Latest from Academy

Tech Deep Dives

SSV

ZRO

APE

SSV Network Just Made Ethereum Staking Safer Than Ever

39 Ethereum validators were slashed in a single correlated event on September 10th, 2025. There was no protocol exploit. No smart contract bug. It was a maintenance window at Ankr where two different infrastructures opened and closed validator keys live at the same time. One human error. One point of failure. Stakers lost ETH.

Archie DuttonApr 26, 2026

9m read

Tech Deep Dives

RPL

MIOTA

DEEP

Why Ethereum Developers Built RocketPool Before Anyone Else Did

RocketPool's initial whitepaper didn't come out until 2018. The Beacon Chain had yet to be created, the merge was still years off, and for most developers the idea of staking was still very much in the future. But if you look at the earliest RocketPool announcements to come out of its GitHub repos the story is a little different: A small team was already writing smart contracts for permissionless node operation months before the 32 ETH deposit contract went live.

Crypto News NavigatorApr 25, 2026

8m read

Altcoins

QNT

LINEA

Arweave Tokenomics Explained Without the Math Degree

The AR token is designed to pay for something else: permanent data storage. That difference informs every aspect of arweave tokenomics. The AR token has a hard capped maximum supply of 66 million tokens, a circulating supply of 65.65 million AR tokens already in circulation, and a current market cap of approximately $138.5 million according to CoinGecko.

Archie DuttonApr 24, 2026

10m read